期刊文献+

叶酸羟丙基-β-环糊精包合物的制备与表征 被引量:7

The Preparation and Characterization of 2-Hydroxypropyl-β-cyclodextrin Folate Acid Inclusion Complexes
下载PDF
导出
摘要 目的制备叶酸羟丙基-β-环糊精包合物,以期提高叶酸的溶解性。方法采用溶液搅拌法制备叶酸羟丙基-β-环糊精包合物,利用核磁共振氢谱1H-NMR、红外光谱、圆二色谱和差示量热扫描对包合物进行表征,运用紫外-可见吸收光谱建立标准曲线方程对包合物中的叶酸进行定量。结果物理混合物图谱与包合物图谱存在显著差别。结论通过与羟丙基-β-环糊精(hydroxypropyl-β-cyclodextrin,HP-β-CD)形成包合物,叶酸的溶解性得到显著提高;叶酸被羟丙基-β-环糊精包合后呈现出新的理化特征,表明形成叶酸羟丙基-β-环糊精包合物。 Objective To prepare the 2 - hydroxypropyl - β - eyclodextrin folate acid inclusion compound, expecting to improve the solubility of folate acid. Methods Solution stirring method was utilized to prepare the 2 - hydroxypropyl - β - cyclodextrin folate acid inclusion complexes. Obtained inclusion complexes were qualified by 1H- NMR, infrared spectrometry, circular dichroism spectroscopy and DSC, and quantified by standard equation set up by Ultraviolet - Visible Absorption Spectroscopy. Results The analysis by nuclear magnetic resonance spectroscopy, infrared spectrometry, circular dichroism spectroscopy and differential scanning calorimetry showed an obvious difference between the inclusion complexes and folate acid. The standard curve equation calculation indicated a great increase in the solubility of folate acid in water. Conclusion Hydroxypropyl - β - eyelodextrin could obviously increase the solubility of folate acid. The inclusion complexes showed some new physical characteristics and those results obtained demonstrated the inclusion complexes were formed.
出处 《医学研究杂志》 2013年第8期98-101,共4页 Journal of Medical Research
关键词 主分子 客分子 手性分子 差示量热扫描 康顿效应 非极性场 包合物 Host molecule Guest molecule Chiral molecule Differential scanning calorimeter Cotton effect Nonpolar field Inclusion complexes
  • 相关文献

参考文献18

  • 1Singh R, Bharti N, Madan J. et al. Characterization of cyclodextrin inclusion complexes [J]. Journal of Pharmaceutical Science and Technology, 2010, 2 (3) :171 -183.
  • 2Loftssan T, Brewter ME. Pharmaceutical application of cyclodextrins 1. Soluhilization and stabilization [J]. J Pharm Sci, 1996, 85 (10) : 1017 -1025.
  • 3Rajewski RA, Stella V J. Pharmaceutical application of cyclodextrins 2. In - vivo[J]. Drug Delivery J Pharm Sci, 1996, 85 (11) : 1142 - 1169.
  • 4Duchene D, Vaution C, Glomot F. Cyclodextrin, their value in pharmaceutical Technology [J]. Drug Dev Ind Ph arm , 1988, 12 (11 - 13) :2193 - 2215.
  • 5Berry RJ, Bailey L, Mulinare J, et al. Fortification of flour with folic acid[J]. Food Nutr Bull, 2010,31 :S22 -S35.
  • 6Hernandez - Diaz S, Martham PH. Folic acid antagonists during pregnancy and the risk of birth defects [J]. The New England Journal of Medicine, 2000, 343(22) :1608 -1614.
  • 7柳时,徐喆,罗智,项光亚.叶酸偶联壳聚糖纳米粒的制备[J].医药导报,2006,25(6):561-563. 被引量:21
  • 8陶凤,席隆一,邓胜伟,余园园,李瑛.叶酸接枝聚乙二醇化壳聚糖衍生物的合成[J].化学研究与应用,2010,22(2):182-185. 被引量:5
  • 9Wang L, Jiang X, Xu W et al. Complexation of tanshinone IIA with 2 - hydroxypropyl - β - cyclodextrin , effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats [J]. Int J Pharm, 2007, 341 (1 - 2) : 58 - 67.
  • 10Jadhav GS, Vavia PR. Physicochemical, in silico and in vivo evaluation of a danazol - β - cyclodextrin complex [J]. Int J Pharm, 2008, 352(1 -2): 5 -16.

二级参考文献16

  • 1柳时,徐喆,罗智,项光亚.叶酸偶联壳聚糖纳米粒的制备[J].医药导报,2006,25(6):561-563. 被引量:21
  • 2Ferber D. Gene Therapy: safer and virus-free? [ J ] Science, 2001,294 : 1638-1642.
  • 3Yang X, Zhang Q, Wang Y,et al. Serf-aggregated nanoparticles from methoxy poly ( ethylene glycol) -modified chitosan: synthesis; characterization; aggregation and methotrexate release in vitro[J]. Colloids and Surfaces B: Biointerfaces, 2008,61: 125-131.
  • 4Sugimoto M, Morimoto M, Saimoto H, et al. Preparation and characterization of water-soluble chitin and chitosan derivatives[ J]. Carbohyd. polym 1998, 36 : 49-59.
  • 5Mansouri S, Cuie Y, Winnik F, et al. Characterization of folate-chitosan-DNA nanoparticles for gene therapy [J]. Biomaterials, 2006, 27: 2060-2065.
  • 6Lee D, Lockey R, Mohapatra S. Folate receptor-mediated cancer cell specific gene dellivery using follic acid-conjugated oligochitosans [ J ] . J. Nanosci Nanotechnol , 2006, 6 : 2860-2866.
  • 7Gorochovceva N, Makuska R. Synthesis and study of watersoluble chitosan-O-poly ( ethylene glycol) graft copolymers [J]. European polymer Journal, 2004, 40: 685-691.
  • 8Kono K, Liu M, Frchet J M J. Design of dendritic macromolecules containing folate or methotrexate residues [ J ]. Bioconjugate Chem,1999, 10: 1115-1121.
  • 9Leamon C P.Folate-mediated targeting:from diagonostics to drug and gene delivery[J].DDT,2001,6(1):44-51.
  • 10Weitman S D.Distribution of the folate receptor GP38 in no-rmal and malignant cell lines and tissues[J].Cancer Res,1992,52(12):3396-3401.

共引文献24

同被引文献47

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部